Evidence map›Paper›PMID 36322090›Full record

ArticleJAMA network open2022

COVID-19 Case Investigation and Contact Tracing in New York City, June 1, 2020, to October 31, 2021.

Kathleen Blaney, Steffen Foerster, Jennifer Baumgartner, Megan Benckert, Janice Blake, Jackie Bray, Shadi Chamany, Katelynn Devinney, Annie Fine, Masha Gindler and 19 more

Abstract read
In one paragraph

Article in JAMA network open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Kathleen BlaneyNew York City Department of Health and Mental Hygiene, Queens, New York.
Steffen FoersterNew York City Department of Health and Mental Hygiene, Queens, New York.
Jennifer BaumgartnerNew York City Department of Health and Mental Hygiene, Queens, New York.
Megan BenckertNew York City Health + Hospitals, New York, New York.
Janice BlakeNew York City Department of Health and Mental Hygiene, Queens, New York.
Jackie BrayNew York City Health + Hospitals, New York, New York.
Shadi ChamanyNew York City Department of Health and Mental Hygiene, Queens, New York.
Katelynn DevinneyNew York City Department of Health and Mental Hygiene, Queens, New York.
Annie FineNew York City Department of Health and Mental Hygiene, Queens, New York.
Masha GindlerNew York City Health + Hospitals, New York, New York.
Laura GuerraNew York City Health + Hospitals, New York, New York.
Amanda JohnsonNew York City Health + Hospitals, New York, New York.
Chris KeeleyNew York City Health + Hospitals, New York, New York.
David LeeNew York City Department of Health and Mental Hygiene, Queens, New York.
Mia LipsitNew York City Health + Hospitals, New York, New York.
Sarah McKenneyNew York City Department of Health and Mental Hygiene, Queens, New York.
Kavita MisraNew York City Department of Health and Mental Hygiene, Queens, New York.
Sarah PerlNew York City Department of Health and Mental Hygiene, Queens, New York.
Dana PetersNew York City Department of Health and Mental Hygiene, Queens, New York.
Madhury RayNew York City Department of Health and Mental Hygiene, Queens, New York.
Eduardo SaadNew York City Department of Health and Mental Hygiene, Queens, New York.
Guajira ThomasNew York City Department of Health and Mental Hygiene, Queens, New York.
Lisa TrieuNew York City Department of Health and Mental Hygiene, Queens, New York.
Chi-Chi UdeaguNew York City Department of Health and Mental Hygiene, Queens, New York.
Julian WatkinsNew York City Department of Health and Mental Hygiene, Queens, New York.
Marcia WongNew York City Department of Health and Mental Hygiene, Queens, New York.
Lindsay ZielinskiNew York City Department of Health and Mental Hygiene, Queens, New York.
Theodore LongNew York City Health + Hospitals, New York, New York.
Neil M VoraNew York City Department of Health and Mental Hygiene, Queens, New York.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Contact tracing is a core strategy for preventing the spread of many infectious diseases of public health concern. Better understanding of the outcomes of contact tracing for COVID-19 as well as the operational opportunities and challenges in establishing a program for a jurisdiction as large as New York City (NYC) is important for the evaluation of this strategy. Objective: To describe the establishment, scaling, and maintenance of Trace, NYC's contact tracing program, and share data on outcomes during its first 17 months. Design, Setting, and Participants: This cross-sectional study included people with laboratory test-confirmed and probable COVID-19 and their contacts in NYC between June 1, 2020, and October 31, 2021. Trace launched on June 1, 2020, and had a workforce of 4147 contact tracers, with the majority of the workforce performing their jobs completely remotely. Data were analyzed in March 2022. Main Outcomes and Measures: Number and proportion of persons with COVID-19 and contacts on whom investigations were attempted and completed; timeliness of interviews relative to symptom onset or exposure for symptomatic cases and contacts, respectively. Results: Case investigations were attempted for 941 035 persons. Of those, 840 922 (89.4%) were reached and 711 353 (75.6%) completed an intake interview (women and girls, 358 775 [50.4%]; 60 178 [8.5%] Asian, 110 636 [15.6%] Black, 210 489 [28.3%] Hispanic or Latino, 157 349 [22.1%] White). Interviews were attempted for 1 218 650 contacts. Of those, 904 927 (74.3%) were reached, and 590 333 (48.4%) completed intake (women and girls, 219 261 [37.2%]; 47 403 [8.0%] Asian, 98 916 [16.8%] Black, 177 600 [30.1%] Hispanic or Latino, 116 559 [19.7%] White). Completion rates were consistent over time and resistant to changes related to vaccination as well as isolation and quarantine guidance. Among symptomatic cases, median time from symptom onset to intake completion was 4.7 days; a median 1.4 contacts were identified per case. Median time from contacts' last date of exposure to intake completion was 2.3 days. Among contacts, 30.1% were tested within 14 days of notification. Among cases, 27.8% were known to Trace as contacts. The overall expense for Trace from May 6, 2020, through October 31, 2021, was approximately $600 million. Conclusions and Relevance: Despite the complexity of developing a contact tracing program in a diverse city with a population of over 8 million people, in this case study we were able to identify 1.4 contacts per case and offer resources to safely isolate and quarantine to over 1 million cases and contacts in this study period.

Indexed as

Contact TracingCOVID-19Cross-Sectional StudiesFemaleHumansNew York CityQuarantine

Identifiers

PMID36322090
PMCPMC9631107

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.